Bath & Body Works, Inc. $BBWI Shares Sold by Aristides Capital LLC

Aristides Capital LLC reduced its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 74.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 10,378 shares of the company’s stock after selling 30,187 shares during the period. Aristides Capital LLC’s holdings in Bath & Body Works were worth $208,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Royal Bank of Canada increased its stake in Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after purchasing an additional 28,815 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after purchasing an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after purchasing an additional 36,684 shares during the last quarter. Intech Investment Management LLC acquired a new position in shares of Bath & Body Works in the first quarter valued at approximately $1,155,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. The Goldman Sachs Group cut their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating for the company in a research note on Thursday, May 28th. UBS Group dropped their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 20th. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. Finally, TD Cowen boosted their price target on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $21.93.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $20.60 on Friday. The business’s fifty day moving average price is $18.77 and its 200 day moving average price is $20.19. The firm has a market capitalization of $4.15 billion, a PE ratio of 5.79, a P/E/G ratio of 2.03 and a beta of 1.42. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter last year, the company earned $0.49 earnings per share. Bath & Body Works’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts expect that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.